Scholars Central

Conference abstractPublished 11 Apr 2022

Zinc carnosine-based modified bismuth quadruple therapy versus standard triple therapy for Helicobacter pylori eradication: A prospective open-label randomized study

Authors: Ali Choukair

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Helicobacter pylori infection is a worldwide problem with increasing burden on the health sector due to its increasing rate of resistance. The conventional triple therapy is becoming obsolete with a high failure rate of eradication, necessitating the need for better alternatives or regimens. Methods: Ninety-two patients with dyspepsia symptoms and positive 13C-urea breath test were randomly assigned in to two groups. The first group (control group) was treated for 14 days using standard triple therapy (TT) protocol: esomeprazole (40 mg twice daily), amoxicillin (1 g twice daily) and clarithromycin (500 mg twice daily). On the other hand, the second group were prescribed a 10-day course of modified bismuth quadruple therapy (MBQT) fortified with zinc carnosine: TT in addition to bismuth subcitrate (240 mg twice daily) and zinc carnosine (75 mg twice daily). A repeated 13C-urea breath test was done 4 weeks after the completion of the eradication therapy. Results: There were no demographic differences between the two groups. The eradication rate was 93.5% (43/46) in the MBQT group compared to 69.6% (32/46) in the TT group (P = 0.003). Besides dizziness, which was recorded in MBQT group, there were no significant differences in side effects between the two groups. Conclusion: 10 days of modified bismuth quadruple therapy fortified with zinc carnosine is superior to 14 days of conventional triple therapy in eradicating Helicobacter pylori infection, with no additional significant adverse events. PDF HTML Digital File

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Hepato-Gastroenterology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hepato-Gastroenterology
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Ali Choukair”